Annual EBITDA
-$92.85 M
-$58.29 M-168.63%
December 31, 2023
Summary
- As of February 8, 2025, CRGX annual EBITDA is -$92.85 million, with the most recent change of -$58.29 million (-168.63%) on December 31, 2023.
- During the last 3 years, CRGX annual EBITDA has fallen by -$87.15 million (-1528.11%).
- CRGX annual EBITDA is now -1528.11% below its all-time high of -$5.70 million, reached on December 31, 2021.
Performance
CRGX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$40.12 M
+$2.15 M+5.09%
September 30, 2024
Summary
- As of February 8, 2025, CRGX quarterly EBITDA is -$40.12 million, with the most recent change of +$2.15 million (+5.09%) on September 30, 2024.
- Over the past year, CRGX quarterly EBITDA has dropped by -$5.70 million (-16.56%).
- CRGX quarterly EBITDA is now -283.59% below its all-time high of -$10.46 million, reached on March 1, 2023.
Performance
CRGX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$147.33 M
-$5.70 M-4.03%
September 30, 2024
Summary
- As of February 8, 2025, CRGX TTM EBITDA is -$147.33 million, with the most recent change of -$5.70 million (-4.03%) on September 30, 2024.
- Over the past year, CRGX TTM EBITDA has dropped by -$74.85 million (-103.26%).
- CRGX TTM EBITDA is now -1307.85% below its all-time high of -$10.46 million, reached on September 1, 2022.
Performance
CRGX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRGX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -168.6% | -16.6% | -103.3% |
| 3 y3 years | -1528.1% | -278.1% | -599.0% |
| 5 y5 years | -1528.1% | -278.1% | -599.0% |
CRGX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
| 5 y | 5-year | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
| alltime | all time | -1528.1% | at low | -283.6% | +5.1% | -1307.8% | at low |
CARGO Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$40.12 M(-5.1%) | -$147.33 M(+4.0%) |
| Jun 2024 | - | -$42.27 M(+24.5%) | -$141.63 M(+21.7%) |
| Mar 2024 | - | -$33.96 M(+9.6%) | -$116.35 M(+25.3%) |
| Dec 2023 | -$92.85 M | -$30.98 M(-10.0%) | -$92.85 M(+28.1%) |
| Sep 2023 | - | -$34.42 M(+102.6%) | -$72.49 M(+49.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$16.99 M(+62.5%) | -$48.53 M(+53.9%) |
| Mar 2023 | - | -$10.46 M(-1.4%) | -$31.54 M(+49.6%) |
| Dec 2022 | -$34.56 M(+506.1%) | -$10.61 M(+1.4%) | -$21.08 M(+101.4%) |
| Sep 2022 | - | -$10.46 M | -$10.46 M |
| Dec 2021 | -$5.70 M | - | - |
FAQ
- What is CARGO Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics annual EBITDA year-on-year change?
- What is CARGO Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics quarterly EBITDA year-on-year change?
- What is CARGO Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for CARGO Therapeutics?
- What is CARGO Therapeutics TTM EBITDA year-on-year change?
What is CARGO Therapeutics annual EBITDA?
The current annual EBITDA of CRGX is -$92.85 M
What is the all time high annual EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high annual EBITDA is -$5.70 M
What is CARGO Therapeutics annual EBITDA year-on-year change?
Over the past year, CRGX annual EBITDA has changed by -$58.29 M (-168.63%)
What is CARGO Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CRGX is -$40.12 M
What is the all time high quarterly EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high quarterly EBITDA is -$10.46 M
What is CARGO Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CRGX quarterly EBITDA has changed by -$5.70 M (-16.56%)
What is CARGO Therapeutics TTM EBITDA?
The current TTM EBITDA of CRGX is -$147.33 M
What is the all time high TTM EBITDA for CARGO Therapeutics?
CARGO Therapeutics all-time high TTM EBITDA is -$10.46 M
What is CARGO Therapeutics TTM EBITDA year-on-year change?
Over the past year, CRGX TTM EBITDA has changed by -$74.85 M (-103.26%)